Skip to main content
Clinical Trials/CTRI/2022/02/039908
CTRI/2022/02/039908
Not yet recruiting
未知

A PROSPECTIVE, OBSERVATIONAL STUDY TO ASSESS THE CHANGES IN NERVE FUNCTION IMPAIRMENT(NFI) AND DISABILITY STATUS IN LEPROSY PATIENTS ON ANTI-LEPROSY TREATMENT

PGIMER0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: A309- Leprosy, unspecified
Sponsor
PGIMER
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
PGIMER

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients who give valid consent/assent.
  • 2\.Patients of either gender with age 14 and above.
  • 3\.All patients being started on anti\-leprosy treatment: multidrug therapy (MDT) or alternative therapy in cases with drug resistanceas per WHO guidelines69

Exclusion Criteria

  • 1\.Patients who are not willing to provide consent for the study.
  • 2\.Patient of age \<14 years
  • 3\.Patients at risk of a neuropathy other than leprosy, i.e. diabetes, alcoholism, risk group for HIV infection, patients with a family history of hereditary neuropathy.

Outcomes

Primary Outcomes

Not specified

Similar Trials